Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-21

Clinical Trial Update: Effects of a Chewing Gum Containing POs-Ca and Fluoride on Enamel [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating a chewing gum containing POs-Ca and fluoride for effects on enamel subsurface lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POs-Ca and Fluoride Chewing Gum (POs-Ca and fluoride chewing gum)

Snippet

Sponsor: Tokyo Medical and Dental University | Conditions: Enamel Subsurface Lesion | EARLY_Phase 1 | Status: COMPLETED